-
1
-
-
77649254732
-
Secondary failure of metformin monotherapy in clinical practice
-
Brown JB, Conner C, Nichols GA. Secondary failure of metformin monotherapy in clinical practice. Diabetes Care 2010; 33: 501-6.
-
(2010)
Diabetes Care
, vol.33
, pp. 501-506
-
-
Brown, J.B.1
Conner, C.2
Nichols, G.A.3
-
2
-
-
58149389215
-
Glucose control and vascular complications in veterans with type 2 diabetes
-
Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-39.
-
(2009)
N Engl J Med
, vol.360
, pp. 129-139
-
-
Duckworth, W.1
Abraira, C.2
Moritz, T.3
-
3
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-59.
-
(2008)
N Engl J Med
, vol.358
, pp. 2545-2559
-
-
Gerstein, H.C.1
Miller, M.E.2
Byington, R.P.3
-
4
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-72.
-
(2008)
N Engl J Med
, vol.358
, pp. 2560-2572
-
-
Patel, A.1
MacMahon, S.2
Chalmers, J.3
-
5
-
-
63149103614
-
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
-
Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009; 32: 187-92.
-
(2009)
Diabetes Care
, vol.32
, pp. 187-192
-
-
Skyler, J.S.1
Bergenstal, R.2
Bonow, R.O.3
-
6
-
-
34250212715
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
-
Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007; 356: 2457-71.
-
(2007)
N Engl J Med
, vol.356
, pp. 2457-2471
-
-
Nissen, S.E.1
Wolski, K.2
-
7
-
-
84871830488
-
-
FDA. Significantly restricts access to the diabetes drug Avandia,. Accessed 23 September 2010.
-
FDA. 2010. Significantly restricts access to the diabetes drug Avandia. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm226956.htm. Accessed 23 September 2010.
-
(2010)
-
-
-
8
-
-
68449094354
-
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
-
Colhoun HM. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 2009; 52: 1755-65.
-
(2009)
Diabetologia
, vol.52
, pp. 1755-1765
-
-
Colhoun, H.M.1
-
9
-
-
79954994764
-
A cohort study of acute pancreatitis in relation to exenatide use
-
Dore DD, Bloomgren GL, Wenten M, et al. A cohort study of acute pancreatitis in relation to exenatide use. Diabetes Obes Metab 2011; 13: 559-66.
-
(2011)
Diabetes Obes Metab
, vol.13
, pp. 559-566
-
-
Dore, D.D.1
Bloomgren, G.L.2
Wenten, M.3
-
10
-
-
79959559653
-
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
-
Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology 2011; 141: 150-6.
-
(2011)
Gastroenterology
, vol.141
, pp. 150-156
-
-
Elashoff, M.1
Matveyenko, A.V.2
Gier, B.3
Elashoff, R.4
Butler, P.C.5
-
11
-
-
80051975559
-
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting
-
Piccinni C, Motola D, Marchesini G, Poluzzi E. Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting. Diabetes Care 2011; 34: 1369-71.
-
(2011)
Diabetes Care
, vol.34
, pp. 1369-1371
-
-
Piccinni, C.1
Motola, D.2
Marchesini, G.3
Poluzzi, E.4
-
12
-
-
38949210220
-
Effect of a multifactorial intervention on mortality in type 2 diabetes
-
Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-91.
-
(2008)
N Engl J Med
, vol.358
, pp. 580-591
-
-
Gaede, P.1
Lund-Andersen, H.2
Parving, H.H.3
Pedersen, O.4
-
13
-
-
67649233262
-
The individualized target HbA1c: a new method for improving macrovascular risk and glycemia without hypoglycemia and weight gain
-
Eldor R, Raz I. The individualized target HbA1c: a new method for improving macrovascular risk and glycemia without hypoglycemia and weight gain. Rev Diabet Stud 2009; 6: 6-12.
-
(2009)
Rev Diabet Stud
, vol.6
, pp. 6-12
-
-
Eldor, R.1
Raz, I.2
-
14
-
-
33646234002
-
Central adiposity, regional fat distribution, and the risk of cholecystectomy in women
-
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut 2006; 55: 708-14.
-
(2006)
Gut
, vol.55
, pp. 708-714
-
-
Tsai, C.J.1
Leitzmann, M.F.2
Willett, W.C.3
Giovannucci, E.L.4
-
15
-
-
22644441020
-
Subcutaneous fat accumulation and BMI associated with risk for pulmonary embolism in patients with proximal deep vein thrombosis: a population study based on 23 796 consecutive autopsies
-
Ogren M, Eriksson H, Bergqvist D, Sternby NH. Subcutaneous fat accumulation and BMI associated with risk for pulmonary embolism in patients with proximal deep vein thrombosis: a population study based on 23 796 consecutive autopsies. J Intern Med 2005; 258: 166-71.
-
(2005)
J Intern Med
, vol.258
, pp. 166-171
-
-
Ogren, M.1
Eriksson, H.2
Bergqvist, D.3
Sternby, N.H.4
-
16
-
-
12544253835
-
Obesity, weight gain, and the risk of kidney stones
-
Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005; 293: 455-62.
-
(2005)
JAMA
, vol.293
, pp. 455-462
-
-
Taylor, E.N.1
Stampfer, M.J.2
Curhan, G.C.3
-
17
-
-
17644371344
-
Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study
-
Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005; 165: 742-8.
-
(2005)
Arch Intern Med
, vol.165
, pp. 742-748
-
-
Choi, H.K.1
Atkinson, K.2
Karlson, E.W.3
Curhan, G.4
-
18
-
-
27644503253
-
Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria
-
Rapp K, Schroeder J, Klenk J, et al. Obesity and incidence of cancer: a large cohort study of over 145, 000 adults in Austria. Br J Cancer 2005; 93: 1062-7.
-
(2005)
Br J Cancer
, vol.93
, pp. 1062-1067
-
-
Rapp, K.1
Schroeder, J.2
Klenk, J.3
-
19
-
-
1642588219
-
Appropriate BMI for Asian populations
-
Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y. Appropriate BMI for Asian populations. Lancet 2004; 363: 1077.
-
(2004)
Lancet
, vol.363
, pp. 1077
-
-
Shiwaku, K.1
Anuurad, E.2
Enkhmaa, B.3
Kitajima, K.4
Yamane, Y.5
-
20
-
-
0001843881
-
Mortality in non-insulin-dependent diabetes
-
In: National Diabetes Data Group (eds), 2nd edn - National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
-
Geiss LS HW, Smith PJ. (1995) Mortality in non-insulin-dependent diabetes. In: National Diabetes Data Group (eds), Diabetes in America. 2nd edn, pp. 233-55. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
-
(1995)
Diabetes in America
, pp. 233-255
-
-
Geiss, L.H.1
Smith, P.J.2
-
21
-
-
50249179853
-
Association between serious ischemic cardiac outcomes and medications used to treat diabetes
-
Margolis DJ, Hoffstad O, Strom BL. Association between serious ischemic cardiac outcomes and medications used to treat diabetes. Pharmacoepidemiol Drug Saf 2008; 17: 753-9.
-
(2008)
Pharmacoepidemiol Drug Saf
, vol.17
, pp. 753-759
-
-
Margolis, D.J.1
Hoffstad, O.2
Strom, B.L.3
-
22
-
-
34547549434
-
Coronary heart disease outcomes in patients receiving antidiabetic agents
-
McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM. Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf 2007; 16: 711-25.
-
(2007)
Pharmacoepidemiol Drug Saf
, vol.16
, pp. 711-725
-
-
McAfee, A.T.1
Koro, C.2
Landon, J.3
Ziyadeh, N.4
Walker, A.M.5
-
24
-
-
0037219411
-
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
-
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-10.
-
(2003)
Diabetes
, vol.52
, pp. 102-110
-
-
Butler, A.E.1
Janson, J.2
Bonner-Weir, S.3
Ritzel, R.4
Rizza, R.A.5
Butler, P.C.6
-
25
-
-
33845405222
-
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
-
Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-43.
-
(2006)
N Engl J Med
, vol.355
, pp. 2427-2443
-
-
Kahn, S.E.1
Haffner, S.M.2
Heise, M.A.3
-
26
-
-
0034121762
-
Diabetes fear of injecting and self-testing questionnaire: a psychometric evaluation
-
Mollema ED, Snoek FJ, Pouwer F, Heine RJ, van der Ploeg HM. Diabetes fear of injecting and self-testing questionnaire: a psychometric evaluation. Diabetes Care 2000; 23: 765-9.
-
(2000)
Diabetes Care
, vol.23
, pp. 765-769
-
-
Mollema, E.D.1
Snoek, F.J.2
Pouwer, F.3
Heine, R.J.4
van der Ploeg, H.M.5
-
27
-
-
35649022136
-
Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire
-
Martinez L, Consoli SM, Monnier L, et al. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire. Health Qual Life Outcomes 2007; 5: 53.
-
(2007)
Health Qual Life Outcomes
, vol.5
, pp. 53
-
-
Martinez, L.1
Consoli, S.M.2
Monnier, L.3
-
28
-
-
77951473452
-
Effect of nateglinide on the incidence of diabetes and cardiovascular events
-
Holman RR, Haffner SM, McMurray JJ, et al. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 2010; 362: 1463-76.
-
(2010)
N Engl J Med
, vol.362
, pp. 1463-1476
-
-
Holman, R.R.1
Haffner, S.M.2
McMurray, J.J.3
-
29
-
-
34547658090
-
Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase
-
Takahashi A, Nagashima K, Hamasaki A, et al. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase. Diabetes Res Clin Pract 2007; 77: 343-50.
-
(2007)
Diabetes Res Clin Pract
, vol.77
, pp. 343-350
-
-
Takahashi, A.1
Nagashima, K.2
Hamasaki, A.3
-
30
-
-
33644772337
-
Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T)
-
Hambrock A, de Oliveira Franz CB, Hiller S, Osswald H. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T). J Pharmacol Exp Ther 2006; 316: 1031-7.
-
(2006)
J Pharmacol Exp Ther
, vol.316
, pp. 1031-1037
-
-
Hambrock, A.1
de Oliveira Franz, C.B.2
Hiller, S.3
Osswald, H.4
-
31
-
-
12244287074
-
Sulfonylurea induced beta-cell apoptosis in cultured human islets
-
Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, Donath MY. Sulfonylurea induced beta-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 2005; 90: 501-6.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 501-506
-
-
Maedler, K.1
Carr, R.D.2
Bosco, D.3
Zuellig, R.A.4
Berney, T.5
Donath, M.Y.6
-
32
-
-
84863031805
-
Exendin-4 protects against sulfonylurea-induced beta-cell apoptosis
-
Kim JY, Lim DM, Park HS, et al. Exendin-4 protects against sulfonylurea-induced beta-cell apoptosis. J Pharmacol Sci 2012; 118: 65-74.
-
(2012)
J Pharmacol Sci
, vol.118
, pp. 65-74
-
-
Kim, J.Y.1
Lim, D.M.2
Park, H.S.3
-
33
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
34
-
-
45949085098
-
A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among military health system beneficiaries, fiscal year 2003-2006
-
Casscells SW, Granger E, Swedorske J, et al. A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among military health system beneficiaries, fiscal year 2003-2006. Am J Ther 2008; 15: 198-205.
-
(2008)
Am J Ther
, vol.15
, pp. 198-205
-
-
Casscells, S.W.1
Granger, E.2
Swedorske, J.3
-
35
-
-
79953056226
-
Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study
-
Horsdal HT, Sondergaard F, Johnsen SP, Rungby J. Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study. Pharmacoepidemiol Drug Saf 2011; 20: 331-7.
-
(2011)
Pharmacoepidemiol Drug Saf
, vol.20
, pp. 331-337
-
-
Horsdal, H.T.1
Sondergaard, F.2
Johnsen, S.P.3
Rungby, J.4
-
36
-
-
0036024167
-
Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits
-
Nieszner E, Posa I, Kocsis E, Pogatsa G, Preda I, Koltai MZ. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits. Exp Clin Endocrinol Diabetes 2002; 110: 212-8.
-
(2002)
Exp Clin Endocrinol Diabetes
, vol.110
, pp. 212-218
-
-
Nieszner, E.1
Posa, I.2
Kocsis, E.3
Pogatsa, G.4
Preda, I.5
Koltai, M.Z.6
-
37
-
-
0032895997
-
Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction
-
Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 1999; 33: 119-24.
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 119-124
-
-
Garratt, K.N.1
Brady, P.A.2
Hassinger, N.L.3
Grill, D.E.4
Terzic, A.5
Holmes Jr, D.R.6
-
38
-
-
31544482787
-
Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study
-
Simpson SH, Majumdar SR, Tsuyuki RT, Eurich DT, Johnson JA. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study. CMAJ 2006; 174: 169-74.
-
(2006)
CMAJ
, vol.174
, pp. 169-174
-
-
Simpson, S.H.1
Majumdar, S.R.2
Tsuyuki, R.T.3
Eurich, D.T.4
Johnson, J.A.5
-
39
-
-
0030974812
-
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study group
-
Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study group. BMJ 1997; 314: 1512-5.
-
(1997)
BMJ
, vol.314
, pp. 1512-1515
-
-
Malmberg, K.1
-
40
-
-
78049489754
-
Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction
-
Zeller M, Danchin N, Simon D, et al. Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction. J Clin Endocrinol Metab 2010; 95: 4993-5002.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 4993-5002
-
-
Zeller, M.1
Danchin, N.2
Simon, D.3
-
41
-
-
79958197888
-
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
-
Schramm TK, Gislason GH, Vaag A, et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J 2011; 32: 1900-8.
-
(2011)
Eur Heart J
, vol.32
, pp. 1900-1908
-
-
Schramm, T.K.1
Gislason, G.H.2
Vaag, A.3
-
42
-
-
33746645098
-
Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: a randomized, open-label, two-period, cross-over trial
-
Papa G, Fedele V, Rizzo MR, et al. Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: a randomized, open-label, two-period, cross-over trial. Diabetes Care 2006; 29: 1918-20.
-
(2006)
Diabetes Care
, vol.29
, pp. 1918-1920
-
-
Papa, G.1
Fedele, V.2
Rizzo, M.R.3
-
43
-
-
60449089649
-
Medical management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the study of diabetes
-
Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 2009; 32: 193-203.
-
(2009)
Diabetes Care
, vol.32
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
44
-
-
19944368427
-
Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine
-
Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005; 28: 1282-8.
-
(2005)
Diabetes Care
, vol.28
, pp. 1282-1288
-
-
Davies, M.1
Storms, F.2
Shutler, S.3
Bianchi-Biscay, M.4
Gomis, R.5
-
45
-
-
72549104985
-
Improved glycaemic control with BIAsp 30 in insulin-naive type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study
-
Wenying Y, Benroubi M, Borzi V, et al. Improved glycaemic control with BIAsp 30 in insulin-naive type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study. Curr Med Res Opin 2009; 25: 2643-54.
-
(2009)
Curr Med Res Opin
, vol.25
, pp. 2643-2654
-
-
Wenying, Y.1
Benroubi, M.2
Borzi, V.3
-
47
-
-
25444470287
-
Weight gain and insulin treatment
-
Larger E. Weight gain and insulin treatment. Diabetes Metab 2005; 31: 4S51-54S56.
-
(2005)
Diabetes Metab
, vol.31
-
-
Larger, E.1
-
48
-
-
35048841093
-
Insulin-associated weight gain in diabetes--causes, effects and coping strategies
-
Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes--causes, effects and coping strategies. Diabetes Obes Metab 2007; 9: 799-812.
-
(2007)
Diabetes Obes Metab
, vol.9
, pp. 799-812
-
-
Russell-Jones, D.1
Khan, R.2
-
49
-
-
12844276465
-
Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
-
Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Jarvinen H. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 2005; 28: 254-9.
-
(2005)
Diabetes Care
, vol.28
, pp. 254-259
-
-
Janka, H.U.1
Plewe, G.2
Riddle, M.C.3
Kliebe-Frisch, C.4
Schweitzer, M.A.5
Yki-Jarvinen, H.6
-
50
-
-
50049096963
-
Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia
-
Davies MJ, Derezinski T, Pedersen CB, Clauson P. Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia. Diabetes Technol Ther 2008; 10: 273-7.
-
(2008)
Diabetes Technol Ther
, vol.10
, pp. 273-277
-
-
Davies, M.J.1
Derezinski, T.2
Pedersen, C.B.3
Clauson, P.4
-
51
-
-
35548947584
-
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
-
Holman RR, Thorne KI, Farmer AJ, et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 2007; 357: 1716-30.
-
(2007)
N Engl J Med
, vol.357
, pp. 1716-1730
-
-
Holman, R.R.1
Thorne, K.I.2
Farmer, A.J.3
-
52
-
-
0034827469
-
Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin
-
Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 2001; 24: 631-6.
-
(2001)
Diabetes Care
, vol.24
, pp. 631-636
-
-
Rosenstock, J.1
Schwartz, S.L.2
Clark Jr, C.M.3
Park, G.D.4
Donley, D.W.5
Edwards, M.B.6
-
53
-
-
0041523870
-
Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients
-
Alvarsson M, Sundkvist G, Lager I, et al. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care 2003; 26: 2231-7.
-
(2003)
Diabetes Care
, vol.26
, pp. 2231-2237
-
-
Alvarsson, M.1
Sundkvist, G.2
Lager, I.3
-
54
-
-
56149118663
-
Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy
-
Chen HS, Wu TE, Jap TS, Hsiao LC, Lee SH, Lin HD. Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy. Diabetes Care 2008; 31: 1927-32.
-
(2008)
Diabetes Care
, vol.31
, pp. 1927-1932
-
-
Chen, H.S.1
Wu, T.E.2
Jap, T.S.3
Hsiao, L.C.4
Lee, S.H.5
Lin, H.D.6
-
55
-
-
43849105857
-
Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial
-
Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 2008; 371: 1753-60.
-
(2008)
Lancet
, vol.371
, pp. 1753-1760
-
-
Weng, J.1
Li, Y.2
Xu, W.3
-
56
-
-
1942535222
-
Self-management support for insulin therapy in type 2 diabetes
-
Funnell MM, Kruger DF, Spencer M. Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ 2004; 30: 274-80.
-
(2004)
Diabetes Educ
, vol.30
, pp. 274-280
-
-
Funnell, M.M.1
Kruger, D.F.2
Spencer, M.3
-
57
-
-
65549151926
-
Nonadherence to insulin therapy in low-income, type 2 diabetic patients
-
Lerman I, Diaz JP, Ibarguengoitia ME, et al. Nonadherence to insulin therapy in low-income, type 2 diabetic patients. Endocr Pract 2009; 15: 41-6.
-
(2009)
Endocr Pract
, vol.15
, pp. 41-46
-
-
Lerman, I.1
Diaz, J.P.2
Ibarguengoitia, M.E.3
-
58
-
-
80051806740
-
First insulinization with basal insulin in patients with type 2 diabetes in a real-world setting in Asia
-
Tsai ST, Pathan F, Ji L, et al. First insulinization with basal insulin in patients with type 2 diabetes in a real-world setting in Asia. J Diabetes 2011; 3: 208-16.
-
(2011)
J Diabetes
, vol.3
, pp. 208-216
-
-
Tsai, S.T.1
Pathan, F.2
Ji, L.3
|